-
Je něco špatně v tomto záznamu ?
Sumoylated NHR-25/NR5A regulates cell fate during C. elegans vulval development
JD. Ward, N. Bojanala, T. Bernal, K. Ashrafi, M. Asahina, KR. Yamamoto,
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, Research Support, N.I.H., Extramural, práce podpořená grantem, Research Support, U.S. Gov't, Non-P.H.S.
NLK
Directory of Open Access Journals
od 2005
Free Medical Journals
od 2005
Public Library of Science (PLoS)
od 2005-07-01
PubMed Central
od 2005
Europe PubMed Central
od 2005
ProQuest Central
od 2005-07-01
Open Access Digital Library
od 2005-01-01
Open Access Digital Library
od 2005-07-01
Open Access Digital Library
od 2005-01-01
Medline Complete (EBSCOhost)
od 2005-07-01
Health & Medicine (ProQuest)
od 2005-07-01
- MeSH
- buněčná diferenciace genetika MeSH
- Caenorhabditis elegans genetika růst a vývoj MeSH
- DNA vazebné proteiny biosyntéza genetika MeSH
- mapy interakcí proteinů MeSH
- protein SUMO-1 genetika metabolismus MeSH
- sekvence aminokyselin MeSH
- signální transdukce genetika MeSH
- sumoylace * MeSH
- transkripční faktory biosyntéza genetika MeSH
- vulva cytologie růst a vývoj MeSH
- vývojová regulace genové exprese MeSH
- zvířata MeSH
- Check Tag
- ženské pohlaví MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Research Support, N.I.H., Extramural MeSH
- Research Support, U.S. Gov't, Non-P.H.S. MeSH
Individual metazoan transcription factors (TFs) regulate distinct sets of genes depending on cell type and developmental or physiological context. The precise mechanisms by which regulatory information from ligands, genomic sequence elements, co-factors, and post-translational modifications are integrated by TFs remain challenging questions. Here, we examine how a single regulatory input, sumoylation, differentially modulates the activity of a conserved C. elegans nuclear hormone receptor, NHR-25, in different cell types. Through a combination of yeast two-hybrid analysis and in vitro biochemistry we identified the single C. elegans SUMO (SMO-1) as an NHR-25 interacting protein, and showed that NHR-25 is sumoylated on at least four lysines. Some of the sumoylation acceptor sites are in common with those of the NHR-25 mammalian orthologs SF-1 and LRH-1, demonstrating that sumoylation has been strongly conserved within the NR5A family. We showed that NHR-25 bound canonical SF-1 binding sequences to regulate transcription, and that NHR-25 activity was enhanced in vivo upon loss of sumoylation. Knockdown of smo-1 mimicked NHR-25 overexpression with respect to maintenance of the 3° cell fate in vulval precursor cells (VPCs) during development. Importantly, however, overexpression of unsumoylatable alleles of NHR-25 revealed that NHR-25 sumoylation is critical for maintaining 3° cell fate. Moreover, SUMO also conferred formation of a developmental time-dependent NHR-25 concentration gradient across the VPCs. That is, accumulation of GFP-tagged NHR-25 was uniform across VPCs at the beginning of development, but as cells began dividing, a smo-1-dependent NHR-25 gradient formed with highest levels in 1° fated VPCs, intermediate levels in 2° fated VPCs, and low levels in 3° fated VPCs. We conclude that sumoylation operates at multiple levels to affect NHR-25 activity in a highly coordinated spatial and temporal manner.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc14074401
- 003
- CZ-PrNML
- 005
- 20141009120306.0
- 007
- ta
- 008
- 141006s2013 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1371/journal.pgen.1003992 $2 doi
- 035 __
- $a (PubMed)24348269
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Ward, Jordan D $u Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, California, United States of America.
- 245 10
- $a Sumoylated NHR-25/NR5A regulates cell fate during C. elegans vulval development / $c JD. Ward, N. Bojanala, T. Bernal, K. Ashrafi, M. Asahina, KR. Yamamoto,
- 520 9_
- $a Individual metazoan transcription factors (TFs) regulate distinct sets of genes depending on cell type and developmental or physiological context. The precise mechanisms by which regulatory information from ligands, genomic sequence elements, co-factors, and post-translational modifications are integrated by TFs remain challenging questions. Here, we examine how a single regulatory input, sumoylation, differentially modulates the activity of a conserved C. elegans nuclear hormone receptor, NHR-25, in different cell types. Through a combination of yeast two-hybrid analysis and in vitro biochemistry we identified the single C. elegans SUMO (SMO-1) as an NHR-25 interacting protein, and showed that NHR-25 is sumoylated on at least four lysines. Some of the sumoylation acceptor sites are in common with those of the NHR-25 mammalian orthologs SF-1 and LRH-1, demonstrating that sumoylation has been strongly conserved within the NR5A family. We showed that NHR-25 bound canonical SF-1 binding sequences to regulate transcription, and that NHR-25 activity was enhanced in vivo upon loss of sumoylation. Knockdown of smo-1 mimicked NHR-25 overexpression with respect to maintenance of the 3° cell fate in vulval precursor cells (VPCs) during development. Importantly, however, overexpression of unsumoylatable alleles of NHR-25 revealed that NHR-25 sumoylation is critical for maintaining 3° cell fate. Moreover, SUMO also conferred formation of a developmental time-dependent NHR-25 concentration gradient across the VPCs. That is, accumulation of GFP-tagged NHR-25 was uniform across VPCs at the beginning of development, but as cells began dividing, a smo-1-dependent NHR-25 gradient formed with highest levels in 1° fated VPCs, intermediate levels in 2° fated VPCs, and low levels in 3° fated VPCs. We conclude that sumoylation operates at multiple levels to affect NHR-25 activity in a highly coordinated spatial and temporal manner.
- 650 _2
- $a sekvence aminokyselin $7 D000595
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a Caenorhabditis elegans $x genetika $x růst a vývoj $7 D017173
- 650 _2
- $a buněčná diferenciace $x genetika $7 D002454
- 650 _2
- $a DNA vazebné proteiny $x biosyntéza $x genetika $7 D004268
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a vývojová regulace genové exprese $7 D018507
- 650 _2
- $a mapy interakcí proteinů $7 D060066
- 650 _2
- $a protein SUMO-1 $x genetika $x metabolismus $7 D025842
- 650 _2
- $a signální transdukce $x genetika $7 D015398
- 650 12
- $a sumoylace $7 D058207
- 650 _2
- $a transkripční faktory $x biosyntéza $x genetika $7 D014157
- 650 _2
- $a vulva $x cytologie $x růst a vývoj $7 D014844
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a Research Support, N.I.H., Extramural $7 D052061
- 655 _2
- $a práce podpořená grantem $7 D013485
- 655 _2
- $a Research Support, U.S. Gov't, Non-P.H.S. $7 D013486
- 700 1_
- $a Bojanala, Nagagireesh $u Institute of Parasitology, Biology Centre ASCR, Ceske Budejovice, Czech Republic ; University of South Bohemia, Ceske Budejovice, Czech Republic.
- 700 1_
- $a Bernal, Teresita $u Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, California, United States of America.
- 700 1_
- $a Ashrafi, Kaveh $u Department of Physiology, University of California San Francisco, San Francisco, California, United States of America. $7 gn_A_00009323
- 700 1_
- $a Asahina, Masako $u Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, California, United States of America ; Institute of Parasitology, Biology Centre ASCR, Ceske Budejovice, Czech Republic ; University of South Bohemia, Ceske Budejovice, Czech Republic. $7 gn_A_00009161
- 700 1_
- $a Yamamoto, Keith R $u Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, California, United States of America.
- 773 0_
- $w MED00008920 $t PLoS genetics $x 1553-7404 $g Roč. 9, č. 12 (2013), s. e1003992
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/24348269 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20141006 $b ABA008
- 991 __
- $a 20141009120655 $b ABA008
- 999 __
- $a ok $b bmc $g 1042284 $s 873313
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2013 $b 9 $c 12 $d e1003992 $i 1553-7404 $m PLoS genetics $n PLoS Genet $x MED00008920
- LZP __
- $a Pubmed-20141006